Brose Sitech acquires Proseat Group
19.09.2025
We advised on the Polish aspects of the multi-jurisdictional sale of the Proseat Group (a producer of foam elements of automotive seats) to Brose Sitech (a producer of automotive seats). The transaction included targets in Poland, Germany, Czechia, and Spain. We provided comprehensive legal support to the Proseat Group in connection with the direct sale of shares in the Polish company Proseat sp. z o.o. Thanks to the transaction, Brose Sitech will broaden its product portfolio to include subcomponents such as foam parts, headrests, and armrests.
Proseat was established in 2003 as a joint venture between the Belgian foam manufacturer Recticel and US-based foam specialist Woodbridge. In 2019 Japanese chemicals supplier Sekisui Kasei acquired a majority stake in Proseat, and in 2022 it became the sole shareholder. Today, Proseat is a leading specialist in automotive seat foam parts and lightweight components made of expanded polypropylene (EPP). Proseat supplies a wide range of clients across Europe, including the Volkswagen Group. The Proseat Group employs over 1,300 people at six plants, including three in Germany and one each in Spain, Czechia and Poland.
Brose Sitech, established in 2022 as a joint venture between Brose and Volkswagen, specialises in the development and production of complete seat systems for automotive manufacturers. In Germany the company operates major plants in Wolfsburg, Emden and Coburg, employing about 2,300 people and supplying just-in-time and just-in-sequence seat and cockpit systems to Volkswagen Group plants.
Wardyński & Partners’ work on the transaction was coordinated by Kacper Czubacki (M&A and corporate), and the team included Marcin Wujczyk (employment), Łukasz Śliwiński and Adrian Budny (M&A and corporate), and Sandra Derdoń and Michał Nowacki (tax).
The seller’s lead counsel was Nishimura & Asahi (London office). The team was led by partners Yoshi Kizu, Tim Merchant, Dominik Kruse, Yutaka ITO, Shingo Ito, Junko Wakabayashi, counsel Kayo Kaneko and Dr Maximilian Lentz, supported by associates Yuki Takada and Aoi Kato.